The analysis demonstrated that over half of the cholesterol biosynthesis genes are significantly downregulated by RORγ antagonist XY018 in both cell lines, including the rate-limiting enzymes HMGCR and SQLE, which are often upregulated in PCa tumors (Figure 2a). This evidence concerns the gene SQLE and posterior cortical atrophy.